Ask AI
ProCE Banner Activity

Biomarker Testing and Immune Checkpoint Inhibitors in NSCLC: Podcast Pearls

PDF
Highlights from our podcast featuring expert answers to questions on current and evolving biomarkers for immune checkpoint inhibitor–based therapies in patients with advanced NSCLC.

Released: August 10, 2020

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Faculty Disclosure

Primary Author

Leora Horn, MD, MSc

Assistant Professor, Hematology Oncology/Medicine
Vanderbilt Ingram Cancer Center
Vanderbilt University
Nashville, Tennessee

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas